Stock NEOG NEOGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Neogen Corporation

Equities

NEOG

US6404911066

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.96 USD -3.31% Intraday chart for Neogen Corporation +0.25% -40.53%
Apr. 18 Neogen Corporation Forms Genomics Relationship with Performance Food Group CI
Apr. 15 Piper Sandler Adjusts Price Target on Neogen to $17 From $19, Maintains Neutral Rating MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company has insufficient levels of profitability.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
NEOGEN CORPORATION Stock Neogen Corporation
-40.53% 2.68B
C
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.92% 185B
C+
MEDTRONIC PLC Stock Medtronic plc
-3.80% 107B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.48% 67.55B
A
DEXCOM, INC. Stock DexCom, Inc.
+11.22% 54.6B
B-
CENCORA, INC. Stock Cencora, Inc.
+16.74% 47.42B
B-
HOYA CORPORATION Stock Hoya Corporation
+2.33% 42.24B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+4.56% 28.24B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.64% 26.42B
B
TERUMO CORPORATION Stock Terumo Corporation
+11.29% 25.66B
A-
Investor Rating
Trading Rating
-
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NEOG Stock
  4. Ratings Neogen Corporation